I. Kobayashi

Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan.

Mitsuaki Suzuki, T. Amikura, M. Sekine, 2006, Gynecologic oncology.

Prognostic Factors of Secondary Ovarian Carcinoma

I. Kobayashi, S. Mizutani, F. Kikkawa, 2002, Oncology.

Randomized Trial of Cisplatin and Carboplatin versus Cisplatin, Vinblastine and Bleomycin in Ovarian Cancer

I. Kobayashi, S. Mizutani, F. Kikkawa, 2000, Gynecologic and Obstetric Investigation.

α-Fetoprotein in malignant germ cell tumors of the ovary

I. Kobayashi, N. Nakashima, Y. Tomoda, 1990 .

Mutational analysis of the estrogen receptor‐α gene in familial ovarian cancer

M. Sekine, Y. Hirai, M. Hatae, 2005 .

Studies on the prevalence of human papillomavirus in pregnant women in Japan

I. Kobayashi, Kenichi Tanaka, K. Takakuwa, 2006, Journal of perinatal medicine.

Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.

S. Tsuji, M. Sekine, Y. Hirai, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25.

S. Tsuji, K. Tanaka, M. Sekine, 2001, Human molecular genetics.

Mutational Analysis of BRCA 1 and BRCA 2 and Clinicopathologic Analysis of Ovarian Cancer in 82 Ovarian Cancer Families : Two Common Founder Mutations of BRCA 1 in Japanese Population 1

Mitsuaki Suzuki, S. Tsuji, M. Sekine, 2001 .

Screening of BRCA1 Mutation Using Immunohistochemical Staining with C‐Terminal and N‐Terminal Antibodies in Familial Ovarian Cancers

Mitsuaki Suzuki, T. Oite, M. Sekine, 2000, Japanese journal of cancer research : Gann.

A randomized trial of cisplatin, vinblastine, and bleomycin versus cyclophosphamide, aclacinomycin, and cisplatin in epithelial ovarian cancer.

I. Kobayashi, F. Kikkawa, K. Tamakoshi, 1997, Oncology.